https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
$0.30
$0.52
Q4 2020 ORGANIC PERFORMANCE
3
Sales
$922
$997
+8%
Operating
Income
EPS
$58
$80
+38%
+73%
• Record 4th quarter sales, adjusted
operating income and adjusted EPS
performance
• All segments delivered year-over-year
sales and operating income growth, led
by consumer and healthcare end markets
• Clariant Masterbatch integration synergy
capture ahead of schedule: $5 million
realized in 2020
($ in millions except EPS)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Q4 2020 SEGMENT PERFORMANCE
4
Sales Operating Income
$100 $100 $100
$922
$100 $100 $100
$997
Distribution CAI SEM Total
2019 2020
$178
$272
$490
$191
$305
$526
SEM Distribution CAI
+8%
+7%
+7%
+12%
$5 $5 $5
$58
$5 $5 $5
$80
Avient CAI SEM Total
$17 $19
$40
$18
$30
$58
Distribution SEM CAI
+38%
+45%
+58%
+6%
(3) (3)
(1) (2)
(1) Total company sales include intercompany sales eliminations
(2) Total company reflects adjusted operating income and includes corporate costs
(3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
2020 HIGHLIGHTS
5
• Completed transformational Clariant Masterbatch acquisition and created new
brand name Avient
• Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier
during the pandemic and due to growth in demand for consumer applications
• Specialty Engineered Materials delivered record operating income on gains from
composites
• Achieved record free cash flow, increased dividend for 10th year in a row and
delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA
• Culture is everything: Certified as a Great Place to Work®
$133
$150
10%
23%8%
21%
4%
15%
2006 2020PF
Healthcare
Consumer
Packaging
Avient Portfolio Transformation
22%
59%
CLARIANT MASTERBATCH:
TRANSFORMATIONAL ACQUISITION
Clariant MB EBITDA Growth
Purchase Price Multiple
10.8
9.6
6.5
2019PF 2020PF 2020PF w/ Full
Synergies
• Acquisition of Clariant Masterbatch
significantly expands presence in
healthcare, packaging and consumer end
markets
• Strength of portfolio – 13% EBITDA growth
as an essential supplier in COVID response
and recovery
• Acquisition completed on July 1, 2020 for
$1.4 billion.
We will deliver for our stakeholders through multiple value creation levers—many of
which are unique to Avient:
o Demand for sustainable solutions, healthcare, and composites, together with Clariant
Masterbatch revenue synergies, that will drive 2021 revenue growth of 8% and long-term growth
in excess of GDP
o Clariant Masterbatch cost synergy capture will result in significant near-term benefit
In addition, we remain committed to increasing annual dividends in line with earnings growth and
opportunistically buying back shares, all while remaining modestly levered.
Avient acquired the Clariant Masterbatch business (CMB) on July 1, 2020 (the “Acquisition Date”).
